Literature DB >> 9730960

Interstitial ATP level and degradation in control and postmyocardial infarcted rats.

A I Kuzmin1, V L Lakomkin, V I Kapelko, G Vassort.   

Abstract

With the aim of estimating interstitial levels and the breakdown process of ATP, cardiac microdialysis was performed in the left ventricular wall of in situ control and postinfarcted as well as of isolated, Langendorff-perfused rat hearts. With the use of a bioluminescence technique for dialysate ATP measurement, the baseline interstitial fluid ATP concentration in in situ hearts was estimated to be 38 +/- 8 nM. Regional ischemia induced an early peak increase in interstitial fluid ATP to 373 +/- 73 nM that correlates with the maximal incidence of ventricular arrhythmias. During continuous infusion of individual adenine nucleotides (50 microM ATP, ADP, or AMP), the dialysate samples were analyzed for adenine nucleotides, nucleosides, and bases using HPLC with ultraviolet detection. The patterns of catabolites were consistent with the major pathway of metabolism, that is, sequential dephosphorylation catalyzed by a chain of separate ecto-nucleotidases. In in situ postinfarcted hearts as well as in perfused hearts, a reduced catabolism rate of extracellular adenine nucleotides was observed. In conclusion, in in situ rat hearts, ATP can be released in substantial amounts in the interstitium where it readily undergoes enzymatic degradation. Dephosphorylation occurs sequentially and faster in in situ control hearts than in in situ postinfarcted or in perfused hearts.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9730960     DOI: 10.1152/ajpcell.1998.275.3.C766

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  16 in total

Review 1.  P2X3 receptor involvement in pain states.

Authors:  Kerstin Wirkner; Beata Sperlagh; Peter Illes
Journal:  Mol Neurobiol       Date:  2007-07-17       Impact factor: 5.590

2.  Could early ischemic arrhythmia triggered by purinergic activation of the transient receptor potential channels be prevented by creatine?

Authors:  Guy Vassort; Patrice Bideaux; Julio Alvarez
Journal:  Exp Clin Cardiol       Date:  2010

Review 3.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

4.  P2X purinergic receptor-mediated ionic current in cardiac myocytes of calsequestrin model of cardiomyopathy: implications for the treatment of heart failure.

Authors:  Jian-Bing Shen; Chunxia Cronin; Dmitry Sonin; Bhalchandra V Joshi; Maria Gongora Nieto; David Harrison; Kenneth A Jacobson; Bruce T Liang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-10-13       Impact factor: 4.733

Review 5.  Extracellular creatine kinase may modulate purinergic signalling.

Authors:  L M Brewster
Journal:  Purinergic Signal       Date:  2020-06-23       Impact factor: 3.765

6.  Role of A(2A)-adenosine receptor activation for ATP-mediated coronary vasodilation in guinea-pig isolated heart.

Authors:  K S Erga; C N Seubert; H X Liang; L Wu; J C Shryock; L Belardinelli
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

7.  The ADP receptor P2Y(1) mediates t-PA release in pigs during cardiac ischemia.

Authors:  Goran K Olivecrona; Matthias Götberg; Jan Harnek; Kenneth A Jacobson; Sverker Jern; David Erlinge
Journal:  J Thromb Thrombolysis       Date:  2007-02-10       Impact factor: 2.300

8.  Regulation of MAPK pathways in response to purinergic stimulation of adult rat cardiac myocytes.

Authors:  Thomais Markou; Guy Vassort; Antigone Lazou
Journal:  Mol Cell Biochem       Date:  2003-01       Impact factor: 3.396

9.  ATP-loaded liposomes effectively protect mechanical functions of the myocardium from global ischemia in an isolated rat heart model.

Authors:  D D Verma; T S Levchenko; E A Bernstein; V P Torchilin
Journal:  J Control Release       Date:  2005-10-17       Impact factor: 9.776

10.  Role of ATP-conductive anion channel in ATP release from neonatal rat cardiomyocytes in ischaemic or hypoxic conditions.

Authors:  Amal K Dutta; Ravshan Z Sabirov; Hiromi Uramoto; Yasunobu Okada
Journal:  J Physiol       Date:  2004-07-22       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.